| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |